ReachMD
Be part of the knowledge.™The Drug Report
The Drug Report® is an innovative series developed and produced in cooperation with Linda R. Bernstein, Pharm.D., Founder and President of Vita Media Corporation and Clinical Professor on the Volunteer Faculty of the School of Pharmacy at the University of California, San Francisco. Dr. Bernstein serves as producer, writer, and host of the series which provides pharmacists, physicians, allied healthcare, and industry professionals with news and information on a wide range of drug-related issues with insights from experts across the nation. Programs will highlight timely drug topics related to pharmacy and therapeutics, drug development, industry milestones, legislative updates, FDA rulings, cutting edge research, and professional trends, along with conference coverage.
Episodes 1-15 of 37
- 6
The Drug Report
Another COVID-19 Vaccine Milestone Reached
Another COVID-19 Vaccine Milestone Reached
- 4
The Drug Report
Second Ebola Virus Treatment Approved
Second Ebola Virus Treatment Approved
- 5
The Drug Report
Lawsuit Against HHS Highlights 340B Drug Pricing Dispute
Lawsuit Against HHS Highlights 340B Drug Pricing Dispute
- 6
The Drug Report
FDA Issues EUA for Pfizer-BioNTech COVID-19 Vaccine
FDA Issues EUA for Pfizer-BioNTech COVID-19 Vaccine
- 5
The Drug Report
Assessing Approvals: FDA Updates on Dexmedetomidine Hydrochloride
Assessing Approvals: FDA Updates on Dexmedetomidine Hydrochloride
- 6
The Drug Report
Assessing the Asthma Management Guideline Updates
Assessing the Asthma Management Guideline Updates
- 5
The Drug Report
The FDA Expands Indication for Baloxavir Marboxil to Include Post-Exposure Influenza Prevention
The FDA Expands Indication for Baloxavir Marboxil to Include Post-Exposure Influenza Prevention
- 5
The Drug Report
A Look into the Development of a COVID-19 Vaccine
A Look into the Development of a COVID-19 Vaccine
- 3
The Drug Report
Measles Vaccination Rates Drop—But Pharmacists Can Help
Measles Vaccination Rates Drop—But Pharmacists Can Help
- 7
The Drug Report
Exploring the Emergency Use Authorization for a Monoclonal Antibody Cocktail for COVID-19
Exploring the Emergency Use Authorization for a Monoclonal Antibody Cocktail for COVID-19
- 5
The Drug Report
Monoclonal Antibody Treatment for COVID-19 Receives FDA Authorization
Monoclonal Antibody Treatment for COVID-19 Receives FDA Authorization
- 3
The Drug Report
CDC Playbook for COVID-19 Vaccine Distribution
CDC Playbook for COVID-19 Vaccine Distribution
- 3
The Drug Report
FDA Approves Remdesivir, the First COVID-19 Treatment
FDA Approves Remdesivir, the First COVID-19 Treatment
- 2
The Drug Report
The DEA’s Adjustment to Schedule II Rules Amid COVID-19
The DEA’s Adjustment to Schedule II Rules Amid COVID-19
- 4
The Drug Report
Coagulopathy in COVID-19: Cause or Effect?
Coagulopathy in COVID-19: Cause or Effect?
